Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$7,181,553
+$1,990,285 QoQ
Shares Held
28,539
+19.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#1,090
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Radnor Capital Management, LLC holds $105,731,738 across 8 Drug Manufacturers - General names. ABBV ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
518,900 | $66,678,650 | |
| 2 | LLY |
ELI LILLY & Co
|
9,442 | $11,325,019 | |
| 3 | JNJ |
Johnson & Johnson
|
42,628 | $10,826,233 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
28,539 | $7,181,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,233 | $4,565,405 | |
| 6 | AMGN |
Amgen Inc
|
6,596 | $2,388,543 | |
| 7 | PFE |
Pfizer Inc
|
77,621 | $1,869,113 | |
| 8 | NVS |
Novartis AG
|
5,725 | $897,222 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,181,553 | 28,539 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $5,191,268 | 23,869 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,493,813 | 24,044 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,804,013 | 25,067 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,675,767 | 25,190 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $5,146,020 | 24,561 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $4,379,771 | 24,647 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,512,654 | 27,915 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $4,348,718 | 25,354 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $4,569,617 | 25,094 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $4,290,344 | 27,685 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $4,086,032 | 27,412 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,421,468 | 25,395 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $2,640,123 | 16,566 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $2,483,299 | 15,366 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,157,157 | 16,073 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,467,867 | 16,113 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $2,536,048 | 15,644 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,059,569 | 15,211 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,284,084 | 11,904 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,290,178 | 11,454 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,223,318 | 11,304 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,179,078 | 11,004 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $916,979 | 10,469 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $944,393 | 9,619 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $622,853 | 8,175 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||